However, a study treating 5 MM patients with CAR CD138 did not report significant toxicities [64], although the efficacy of the treatment was limited, with only stable disease observed in 4 out of 5 patients that eventually progressed [64]. Here, SDC1 is linked to Miyoshi myopathy.